Andrieux, Joris <br/><br/>
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis.  [electronic resource] 

 -  Cancer genetics and cytogenetics  Oct 2007 
 - 11-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0165-4608 
<br/><br/><label>Standard No.: </label>10.1016/j.cancergencyto.2007.06.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged, 80 and over<br/>Bone Morphogenetic Proteins--antagonists & inhibitors<br/>Carrier Proteins--physiology<br/>Chromosomes, Human, Pair 17<br/>Chromosomes, Human, X<br/>Female<br/>Gene Expression Regulation<br/>Humans<br/>Male<br/>Middle Aged<br/>Myeloproliferative Disorders--genetics<br/>Osteosclerosis--genetics<br/>Primary Myelofibrosis--genetics<br/>Translocation, Genetic